Health Tip: Amusement Park Safety

News Consumer News Health Tip: Amusement Park Safety — Ferris wheels and roller coasters are summer staples for many. Unfortunately, more than 30,000 emergency room visits in 2016 were linked to amusement parks and carnivals, says the University of Michigan. The school encourages parents to: Speak up if park employees are exhibiting unsafe behaviors. Only […]

Continue Reading

Pretomanid Approved for Treatment of Drug-Resistant TB

WEDNESDAY, Aug. 14, 2019 — Pretomanid tablets in combination with bedaquiline and linezolid have been approved for the treatment of a highly treatment-resistant type of pulmonary tuberculosis (TB), the U.S. Food and Drug Administration announced today. The treatment combination was approved to treat adult patients with extensively drug-resistant, treatment-intolerant, or nonresponsive multidrug-resistant pulmonary TB. Dosing […]

Continue Reading

Lynparza Phase III PAOLA-1 trial met primary endpoint as 1st-line maintenance treatment with bevacizumab for advanced ovarian cancer

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced positive results from the Phase III PAOLA-1 trial in women with advanced ovarian cancer. The trial, in the 1st-line maintenance setting, compared Lynparza (olaparib) added to standard-of-care (SoC) bevacizumab vs. bevacizumab alone in women […]

Continue Reading